Exelixis Clinical Site #123 — East Brunswick, New Jersey

Exelixis Clinical Site #123 is a clinical research site located in East Brunswick, New Jersey, United States 08816.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #123 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Prostate Cancer, Prostate Adenocarcinoma.

Sponsors: Exelixis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Brunswick

Browse all research sites in New Jersey · View every site in East Brunswick

• Astera Cancer Care
• Astera Cancer Care East Brunswick
• Research Site
• START New Jersey
• UniMed Center
• Regional Cancer Care Associates
• START, Astera
• Titan Health Partners LLC, d/b/a Astera Cancer Care /ID# 221003
• Central Jersey Oncology Center
• Astera Cancer Center
• GSK Investigational Site
• Regional Cancer Care Associates, Central Jersey Division

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #123?

Exelixis Clinical Site #123 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #123 conducted?

Exelixis Clinical Site #123 has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Prostate Cancer, Prostate Adenocarcinoma.

Is Exelixis Clinical Site #123 accredited by Crixeo Clinical Trials?

Exelixis Clinical Site #123 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #123?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.